AMCAL NICOTINE LOZENGES 2mg nicotine (as nicotine polacrilex) lozenge blister pack

Land: Australien

Sprog: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv bestanddel:

nicotine polacrilex, Quantity: 13.33 mg (Equivalent: nicotine, Qty 2 mg)

Tilgængelig fra:

Orion Laboratories Pty Ltd T/A Perrigo Australia

INN (International Name):

Nicotine polacrilex

Lægemiddelform:

Tablet, uncoated

Sammensætning:

Excipient Ingredients: mannitol; sodium carbonate; xanthan gum; potassium bicarbonate; sodium alginate; magnesium stearate; aspartame; Flavour

Indgivelsesvej:

Buccal

Enheder i pakken:

120, 108, 96, 156, 36, 144, 132, 168, 72

Recept type:

Not Scheduled after consideration by Committee

Terapeutiske indikationer:

Relief of nicotine withdrawal symptoms including cravings associated with smoking cessation. Nicotine Lozenges may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping smoking. If possible, when stopping smoking, should be used in conjunction with behavioural support program.

Produkt oversigt:

Visual Identification: Cream/white embossed biconvex round tablet with an odour of peppermint. Embossed with 'L344' on one face.; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Autorisation status:

Licence status A

Autorisation dato:

2013-08-15